News
NO/LAAN Newsletter : Q3 2023

NO/LAAN Newsletter : Q3 2023

The NO/LA Angel Network's Fall 2023 Newsletter is here! Please click to learn more about NO/LAAN’s third quarter of 2023 and to sign-up for future newsletters.

NO/LAAN Newsletter : Q2 2023

NO/LAAN Newsletter : Q2 2023

The NO/LA Angel Network's Summer 2023 Newsletter is here! Please click to learn more about NO/LAAN’s second quarter of 2023 and to sign-up for future newsletters.

2023 NOLAAN Investor Conference Sponsorships

2023 NOLAAN Investor Conference Sponsorships

The NO/LA Angel Network's Annual Investor Conference will take place November 9 - 10, 2023. If you have interest in becoming a sponsor for this conference, we are offering multiple tiers of sponsorship with a variety of sponsor-benefits. Please take a look at our...

NO/LAAN Newsletter : Q1 2023

NO/LAAN Newsletter : Q1 2023

The NO/LA Angel Network is proud to announce the beginning of our quarterly newsletter! Please click to learn more about NO/LAAN's first quarter of 2023 and to sign-up for future newsletters.

Embera Wins $11.1M NIDA Grant to Develop Addiction Treatment

Embera Wins $11.1M NIDA Grant to Develop Addiction Treatment

Embera NeuroTherapeutics has received an $11.1 million, 3-year grant from the NIH’s National Institute on Drug Abuse (NIDA) to support continued clinical development of its cocaine addiction treatment EMB-001. “With this support, we are excited to continue the...